Showing 5911-5920 of 6035 results for "".
- Alcon Unveils Next-Generation Forceps to Improve Precision and Reduce Trauma During Retina Surgeryhttps://modernod.com/news/alcon-unveils-next-generation-forceps-to-improve-precision-and-reduce-trauma-during-retina-surgery/2479998/Alcon has launched the new Finesse Sharkskin ILM Forceps at the the American Society of Retina Specialists (ASRS) meeting. The next-generation tool is designed to provide increased surgical precision and to enhance retina surgery outcomes. The new forceps have a large grasping platform and a text
- Aerie Pharmaceuticals Announces Early Notification of FDA Acceptance of NDA Submission for Roclatanhttps://modernod.com/news/aerie-pharmaceuticals-announces-early-notification-of-fda-acceptance-of-nda-submission-for-roclatan/2479999/Aerie Pharmaceuticals reported that it has received the “Day 74” notification from the FDA earlier than scheduled. The FDA has completed its initial 60-day review of the new drug application (NDA) for Roclatan (netarsudil/latanoprostnetarsudil ophthalmic solution) 0.02%/0.005% and the FDA has det
- Allergan and Molecular Partners Announce Positive Phase 3 Clinical Trials for Abicipar Pegol for the Treatment of Wet AMDhttps://modernod.com/news/allergan-and-molecular-partners-announce-positive-phase-3-clinical-trials-for-abicipar-pegol-for-the-treatment-of-wet-amd/2480008/Allergan and Molecular Partners announced the release of two positive clinical trials, SEQUOIA and CEDAR, for abicipar, demonstrating that both the 8-week and 12-week treatment regimens met the prespecified primary endpoint of noninferiority to ranibizumab. SEQUOIA and CEDAR are identical
- FDA Releases Action Plan to Speed Up Market Entry for Biosimilarshttps://modernod.com/news/fda-releases-action-plan-to-speed-up-market-entry-for-biosimilars/2480010/The FDA unveiled plans Wednesday designed to facilitate the development, approval and market entry of biosimilars in the US. The Biosimilars Action Plan (BAP) “is aimed at promoting competition and affordability across the market for biologics and biosimilar products,” commented FDA C
- The Foundation Fighting Blindness Presents the Emerging Science Showcase at OIS Retina 2018https://modernod.com/news/the-foundation-fighting-blindness-presents-the-emerging-science-showcase-at-ois-retina-2018/2480012/The Foundation Fighting Blindness (FFB) Emerging Science Showcase will lead off the upcoming Ophthalmology Innovation Summit for Retina, held July 20, 2018, in Vancouver, B.C., Canada. Moderated by FFB COO Jaso
- Sheraz Daya, MD, Introduces the Daya ICL Forcepshttps://modernod.com/news/sheraz-daya-md-introduces-the-daya-icl-forceps/2480015/In partnership with MST, Sheraz Daya, MD, has co-created an ICL loading system that ensures true confidence in loading and positioning. The design of the forceps allow the user to pull the ICL into the injection cartr
- RETINA-AI Releases the First Artificial Intelligence Mobile App for Eye Care Providershttps://modernod.com/news/retina-ai-releases-the-first-artificial-intelligence-mobile-app-for-eye-care-providers/2480018/RETINA-AI has developed and released the first artificial intelligence mobile app for eye care providers. The app, called Fluid Intelligence by RETINA-AI, detects macular edema and subretinal fluid on OCT retinal scans with greater than 90% accuracy, according to a company news release. Fl
- Practice-Hospital Consolidation Increasing for Many Specialtieshttps://modernod.com/news/practice-hospital-consolidation-increasing-for-many-specialties/2480021/The level of integration of certain primary care practices into health systems and hospitals more than doubled in recent years, with steeper increases seen in the fields of oncology and cardiology, according to research publish
- Zeiss Names New Chief Financial Officerhttps://modernod.com/news/zeiss-names-news-chief-financial-officer/2480025/Christian Müller, PhD, will become Chief Financial Officer of Carl Zeiss AG, succeeding Thomas Spitzenpfeil who, as previously announced, will leave the company. Dr. Müller has been CFO of the Zeiss subsidiary Carl Zeiss Meditec AG since 2009. He joined the Zeiss Group in 2002 as head of Corporat
- Lightmed Announces New Office Location in Caesarea, Israelhttps://modernod.com/news/lightmed-announces-new-office-location-in-caesarea-israel/2480027/Lightmed announced it has opened a new office location in Caesarea, Israel to expand its business and technological investments, and leverage Israel’s diverse and experienced medical technology talent pool. “Th